Intel beats VLSI in $3.1bn Texas suit

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Intel beats VLSI in $3.1bn Texas suit

adobestock-288834591-editorial-use-only.jpeg

In the second trial of three, Intel punches back at VLSI after a $2.18 billion verdict from the same court in March

In a surprise turn of events at the District Court for the Western District of Texas yesterday, April 21, a jury ruled in favour of Intel in the tech company’s second patent trial against VLSI Technology, in which the latter was seeking $3.1 billion in damages.

The news comes less than two months after a jury in the same court ruled against Intel, delivering a record-breaking $2.18 billion damages award to VLSI, a unit of the hedge fund Fortress Investment Group.

Intel is seeking a new trial in that case, and has said it intends to appeal the $2.18 billion verdict.

Related stories

Yesterday’s ruling, made in Waco, was handed down in the fourth patent trial to take place in Alan Albright’s court since his appointment in 2018 and it was the third victory for a defendant. The first was in MV3 v Roku, which ended in December 2020.

VLSI sued Intel at the Western District of Texas in April 2019, alleging that the tech company had infringed its patent pertaining to speed shift technology.

A third trial in Albright’s court over similar patented technology is scheduled for June.

more from across site and SHARED ros bottom lb

More from across our site

In the first of a two-part article, lawyers at Spruson & Ferguson and Marshall Gerstein provide an overview of China’s system for appealing against patent invalidation decisions
Lawyers and corporate leaders at INTA’s Business of M&A conference in New York discussed how cross-practice collaboration and early in-house involvement can help deals
Lily Li, partner at Morrison Foerster, shares how her litigation team helped secure victory at the ITC in a patent infringement case
Top talking points also included news of an appellate ruling concerning ‘Pisco’ and Indian drugmakers gearing up to launch generic versions of Ozempic as Novo Nordisk’s patent expires
The government’s keenly awaited view on AI and copyright has positive themes but leaves rights owners wanting, says Rebecca Newman at Addleshaw Goddard
While IP Australia’s updated manual could be favourable to computer-implemented inventions, stakeholders would like to see whether a consistent and reliable standard is followed during actual examination
UKIPO will remain a competitive option as long as efficient service continues
A future opt-out has not been ruled out, but practitioners warn that the UK could fall behind in the AI race
US patent lawyers say they are increasingly advising clients on China strategies as corporations seek to gain leverage in enforcement, licensing, and supply chain management
Mike Rueckheim reunites with 12 of his former Winston & Strawn colleagues as King & Spalding continues aggressive hiring streak
Gift this article